BOSTON SCIENTIFIC CORP (1BSX.MI) Stock Fundamental Analysis
Europe - BIT:1BSX - US1011371077 - Common Stock
83 EUR
-0.2 (-0.24%)
1BSX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. While 1BSX has a great profitability rating, there are some minor concerns on its financial health. 1BSX is valued quite expensively, but it does show have an excellent growth rating. These ratings would make 1BSX suitable for growth investing!
1. Profitability
1.1 Basic Checks
1BSX had positive earnings in the past year.
In the past year 1BSX had a positive cash flow from operations.
Of the past 5 years 1BSX 4 years were profitable.
1BSX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
1BSX has a Return On Assets of 6.03%. This is in the better half of the industry: 1BSX outperforms 73.68% of its industry peers.
With a decent Return On Equity value of 11.17%, 1BSX is doing good in the industry, outperforming 71.93% of the companies in the same industry.
1BSX has a better Return On Invested Capital (7.66%) than 70.18% of its industry peers.
1BSX had an Average Return On Invested Capital over the past 3 years of 6.54%. This is below the industry average of 9.00%.
The 3 year average ROIC (6.54%) for 1BSX is below the current ROIC(7.66%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.03% | ||
| ROE | 11.17% | ||
| ROIC | 7.66% |
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.54%
ROIC(5y)5.68%
1.3 Margins
With an excellent Profit Margin value of 13.54%, 1BSX belongs to the best of the industry, outperforming 80.70% of the companies in the same industry.
1BSX's Profit Margin has declined in the last couple of years.
The Operating Margin of 1BSX (18.69%) is better than 82.46% of its industry peers.
In the last couple of years the Operating Margin of 1BSX has remained more or less at the same level.
The Gross Margin of 1BSX (68.30%) is better than 77.19% of its industry peers.
In the last couple of years the Gross Margin of 1BSX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.69% | ||
| PM (TTM) | 13.54% | ||
| GM | 68.3% |
OM growth 3Y0.33%
OM growth 5Y1.13%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.3%
GM growth 5Y-0.65%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1BSX is destroying value.
1BSX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for 1BSX has been increased compared to 5 years ago.
1BSX has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.82 indicates that 1BSX is not in any danger for bankruptcy at the moment.
The Altman-Z score of 1BSX (5.82) is better than 89.47% of its industry peers.
The Debt to FCF ratio of 1BSX is 3.33, which is a good value as it means it would take 1BSX, 3.33 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.33, 1BSX belongs to the top of the industry, outperforming 80.70% of the companies in the same industry.
1BSX has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
1BSX's Debt to Equity ratio of 0.50 is in line compared to the rest of the industry. 1BSX outperforms 43.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 3.33 | ||
| Altman-Z | 5.82 |
ROIC/WACC0.93
WACC8.27%
2.3 Liquidity
A Current Ratio of 1.37 indicates that 1BSX should not have too much problems paying its short term obligations.
1BSX has a Current ratio (1.37) which is in line with its industry peers.
A Quick Ratio of 0.82 indicates that 1BSX may have some problems paying its short term obligations.
The Quick ratio of 1BSX (0.82) is worse than 61.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
1BSX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.91%, which is quite impressive.
Measured over the past years, 1BSX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.56% on average per year.
The Revenue has grown by 21.45% in the past year. This is a very strong growth!
Measured over the past years, 1BSX shows a quite strong growth in Revenue. The Revenue has been growing by 9.30% on average per year.
EPS 1Y (TTM)26.91%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%20.97%
Revenue 1Y (TTM)21.45%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%22.84%
3.2 Future
Based on estimates for the next years, 1BSX will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.08% on average per year.
1BSX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.70% yearly.
EPS Next Y20.01%
EPS Next 2Y16.91%
EPS Next 3Y15.57%
EPS Next 5Y14.08%
Revenue Next Year19.61%
Revenue Next 2Y15.21%
Revenue Next 3Y13.52%
Revenue Next 5Y11.7%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 34.30 indicates a quite expensive valuation of 1BSX.
Compared to the rest of the industry, the Price/Earnings ratio of 1BSX is on the same level as its industry peers.
1BSX's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.86.
Based on the Price/Forward Earnings ratio of 28.30, the valuation of 1BSX can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1BSX is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.32. 1BSX is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.3 | ||
| Fwd PE | 28.3 |
4.2 Price Multiples
1BSX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1BSX is more expensive than 63.16% of the companies in the same industry.
1BSX's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.29 | ||
| EV/EBITDA | 35.08 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of 1BSX may justify a higher PE ratio.
1BSX's earnings are expected to grow with 15.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.71
PEG (5Y)3.59
EPS Next 2Y16.91%
EPS Next 3Y15.57%
5. Dividend
5.1 Amount
1BSX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1BSX (10/2/2025, 7:00:00 PM)
83
-0.2 (-0.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners93.45%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap122.99B
Analysts85
Price Target107.05 (28.98%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.53%
Min EPS beat(2)2.49%
Max EPS beat(2)10.56%
EPS beat(4)4
Avg EPS beat(4)6.23%
Min EPS beat(4)2.49%
Max EPS beat(4)10.56%
EPS beat(8)8
Avg EPS beat(8)6.12%
EPS beat(12)11
Avg EPS beat(12)5.14%
EPS beat(16)15
Avg EPS beat(16)4.28%
Revenue beat(2)2
Avg Revenue beat(2)1.7%
Min Revenue beat(2)0.97%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)2.15%
Min Revenue beat(4)0.97%
Max Revenue beat(4)3.16%
Revenue beat(8)8
Avg Revenue beat(8)2.1%
Revenue beat(12)11
Avg Revenue beat(12)2.01%
Revenue beat(16)12
Avg Revenue beat(16)1.41%
PT rev (1m)2.34%
PT rev (3m)1.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.36%
EPS NY rev (1m)2.19%
EPS NY rev (3m)2.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.75%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)1.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.3 | ||
| Fwd PE | 28.3 | ||
| P/S | 7.78 | ||
| P/FCF | 41.29 | ||
| P/OCF | 33.58 | ||
| P/B | 6.42 | ||
| P/tB | N/A | ||
| EV/EBITDA | 35.08 |
EPS(TTM)2.42
EY2.92%
EPS(NY)2.93
Fwd EY3.53%
FCF(TTM)2.01
FCFY2.42%
OCF(TTM)2.47
OCFY2.98%
SpS10.67
BVpS12.93
TBVpS-1.68
PEG (NY)1.71
PEG (5Y)3.59
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.03% | ||
| ROE | 11.17% | ||
| ROCE | 9.51% | ||
| ROIC | 7.66% | ||
| ROICexc | 7.77% | ||
| ROICexgc | 26.52% | ||
| OM | 18.69% | ||
| PM (TTM) | 13.54% | ||
| GM | 68.3% | ||
| FCFM | 18.84% |
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.54%
ROIC(5y)5.68%
ROICexc(3y)6.7%
ROICexc(5y)5.9%
ROICexgc(3y)22.68%
ROICexgc(5y)19.43%
ROCE(3y)8.12%
ROCE(5y)7.05%
ROICexcg growth 3Y8.56%
ROICexcg growth 5Y6.81%
ROICexc growth 3Y4.36%
ROICexc growth 5Y5.23%
OM growth 3Y0.33%
OM growth 5Y1.13%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.3%
GM growth 5Y-0.65%
F-Score5
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 3.33 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 60.84% | ||
| Cap/Sales | 4.33% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 89.77% | ||
| Profit Quality | 139.08% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 5.82 |
F-Score5
WACC8.27%
ROIC/WACC0.93
Cap/Depr(3y)57.82%
Cap/Depr(5y)54.13%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.85%
Profit Quality(3y)134.31%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.91%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%20.97%
EPS Next Y20.01%
EPS Next 2Y16.91%
EPS Next 3Y15.57%
EPS Next 5Y14.08%
Revenue 1Y (TTM)21.45%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%22.84%
Revenue Next Year19.61%
Revenue Next 2Y15.21%
Revenue Next 3Y13.52%
Revenue Next 5Y11.7%
EBIT growth 1Y26.44%
EBIT growth 3Y12.47%
EBIT growth 5Y10.54%
EBIT Next Year35.67%
EBIT Next 3Y20.23%
EBIT Next 5Y14.94%
FCF growth 1Y131.03%
FCF growth 3Y26.15%
FCF growth 5Y16.61%
OCF growth 1Y101.7%
OCF growth 3Y22.44%
OCF growth 5Y13.34%